Correct Answer: A. Intravenous amiodarone
The ECG pattern described (though image not visible) in a patient with CAD presenting with chest pain and palpitations most likely shows ventricular tachycardia (VT) or a haemodynamically unstable arrhythmia. In acute, haemodynamically significant arrhythmias complicating acute coronary syndrome (ACS), intravenous amiodarone is the drug of choice per Indian guidelines (CSIR/ICMR protocols) and Harrison's recommendations. Amiodarone is a Class III antiarrhythmic with properties of all four Vaughan-Williams classes, making it uniquely effective for both supraventricular and ventricular arrhythmias in the acute setting. The IV formulation achieves rapid therapeutic levels (onset 3–5 minutes), critical in haemodynamically unstable patients where oral absorption is unreliable and delayed. In ACS with VT, IV amiodarone suppresses ectopic foci, prolongs refractoriness, and stabilises the myocardium without the negative inotropic effects that beta-blockers carry in acute decompensation. The dose is typically 150 mg IV bolus over 10 minutes, repeated as needed. Oral amiodarone requires loading over days and is unsuitable for acute management. Beta-blockers, while useful for chronic CAD, are contraindicated or require extreme caution in acute VT with haemodynamic compromise due to their negative inotropic and chronotropic effects, risking cardiogenic shock.
Why the other options are wrong
B. Oral amiodarone — Oral amiodarone has a slow onset of action (hours to days for loading) and unpredictable absorption in acute settings, especially with compromised perfusion. In acute VT complicating ACS, the patient requires immediate rhythm control; oral formulation cannot achieve therapeutic levels fast enough to prevent haemodynamic collapse or sudden cardiac death. This is a trap for students who know amiodarone is effective but miss the critical distinction between acute and chronic dosing routes. C. Oral metoprolol — Oral beta-blockers are contraindicated in acute VT with haemodynamic instability. Metoprolol's negative inotropic effect worsens cardiac output in an already compromised heart, and its slow onset (30–60 minutes) delays definitive rhythm control. While beta-blockers are standard in chronic CAD management, they are inappropriate for acute arrhythmia suppression in the setting of ACS. This option exploits confusion between chronic and acute CAD management. D. Intravenous metoprolol — Although IV metoprolol has faster onset than oral (5–10 minutes), it remains contraindicated in acute VT with haemodynamic compromise. Beta-blockers reduce contractility and heart rate, risking cardiogenic shock in a patient already experiencing chest pain and palpitations from acute ischaemia. Amiodarone's superior safety profile in acute VT (no negative inotropic effect) and broader antiarrhythmic spectrum make it the clear choice over beta-blockers in this scenario.
High-Yield Facts
- IV amiodarone 150 mg bolus is first-line for acute VT/haemodynamically unstable arrhythmias in ACS; onset 3–5 minutes.
- Oral amiodarone requires 5–7 days of loading to reach steady state; unsuitable for acute management.
- Beta-blockers are contraindicated in acute VT with haemodynamic instability due to negative inotropic effects and risk of cardiogenic shock.
- Amiodarone is Class III + properties of Classes I, II, IV, making it uniquely effective for both SVT and VT in acute settings.
- In Indian ACS guidelines (CSIR/ICMR), IV amiodarone is preferred over IV lignocaine for VT post-MI due to superior efficacy and safety.
Mnemonics
ACUTE VT in ACS → AMIO (IV) Acute Myocardial Infarction with Outstanding arrhythmia → IV Amiodarone. Remember: IV for acute, oral for chronic loading. Use when you see 'acute,' 'haemodynamically unstable,' or 'VT post-MI.' Beta-blockers = NEGATIVE in acute VT Negative inotrope, Exacerbates shock, Generally contraindicated in acute VT. Avoid beta-blockers when the patient is already haemodynamically compromised. Save them for chronic CAD management post-stabilisation.
NBE Trap
NBE pairs amiodarone (correct) with oral route to trap students who know amiodarone is effective but confuse acute dosing (IV bolus) with chronic loading (oral). The presence of 'amiodarone' in two options tests whether the student understands route-dependent pharmacokinetics in emergency cardiology.
Clinical Pearl
In Indian emergency departments, IV amiodarone is the go-to drug for post-MI VT because it works fast, doesn't crash the blood pressure (unlike beta-blockers), and covers both atrial and ventricular arrhythmias—critical when you don't have time to wait for oral loading or ECG clarification in a haemodynamically unstable patient.
_Reference: Harrison Ch. 242 (Arrhythmias); KD Tripathi Ch. 31 (Antiarrhythmics); Robbins Ch. 12 (Acute Myocardial Infarction)_